251280 fundamentals

AngioLab, Inc. engages in the development, manufacture, and distribution of pharmaceutical products. Its products include treatment for wet macular degeneration, nonalcoholic fatty liver disease treatment, periodontal disease treatment, treatment of otitis media with effusion, injection dermatitis remedy, antibody therapy, and foods that reduce visceral fat. The company was founded by Min-Yeong Kim on June 3, 1999 and is headquartered in Daejeon, South Korea.